# Cerebral iron deposition in the Globus pallidus and Substantia nigra of aging dogs and cats presenting as bilateral hypointensity on T2w and iron-sensitive MRI sequences (SWI, T2*)

**Authors:** Carolin Fischer, Sebastian Schaub, Svenja Susanne Erika Körber, Monika Isabel Hoppe, Kathrin Büttner, Martin Jürgen Schmidt

PMC · DOI: 10.3389/fvets.2026.1706134 · Frontiers in Veterinary Science · 2026-02-11

## TL;DR

The study found that aging dogs show increased brain iron deposits detectable via MRI, with visibility influenced by age and MRI field strength.

## Contribution

The study identifies age and MRI field strength as significant factors in detecting cerebral iron accumulation in aging dogs using advanced MRI sequences.

## Key findings

- Age is a significant predictor of cerebral iron deposit visibility in dogs.
- Higher MRI field strengths (1.5T and 3T) improve visibility of iron deposits compared to 1T in dogs.
- Iron-sensitive sequences (SWI, T2*) outperform T2w in detecting iron deposits in canines.

## Abstract

With aging, dysregulation of brain iron homeostasis can lead to cerebral iron accumulation, a process associated with the pathogenesis of neurodegenerative diseases and recognized as an imaging marker in humans. Similarly, MRI-detected cerebral iron accumulation has been reported in aging beagles, suggesting parallels with human findings.

Single-center, observational study that retrospectively and prospectively evaluated 236 client-owned animals (198 dogs, 38 cats) undergoing brain MRI between 2014 and 2024. Patients represented various breeds and ages; scans were performed at different field strengths, 1-3 Tesla (T), with each animal examined once at a single field strength. MRIs were evaluated for bilateral hypointensities in T2-weighted (T2w) and iron-sensitive imaging (SWI, T2*) in the Globus pallidus and Substantia nigra. In selected cases, iron deposition was validated via post-mortem iron-sensitive Perl’s staining of fixed brain tissues.

Logistic regression analysis identified age as a significant predictor of improved visibility (OR = 1.21, p < 0.0001). Compared with 1T, 1.5T increased the odds of visibility by 2.78-fold (p = 0.0366), and 3T by 4.82-fold (p < 0.001). Species-specific analysis showed that, in cats, field strength had no significant effect (p = 0.1575), whereas age remained a significant predictor (p = 0.0192). Iron-sensitive sequences (SWI, T2*) provided superior visibility of iron deposits compared to T2w, particularly in dogs. No significant difference in hypointensity detection was observed between the two brain regions.

In summary, age and MRI field strength significantly affect the visibility of cerebral iron deposits in dogs, whereas feline results require further investigation due to the limited sample size. SWI and T2* enhance iron detection compared to T2w, particularly in canines.

## Linked entities

- **Species:** Canis lupus familiaris (taxon 9615), Felis catus (taxon 9685)

## Full-text entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}
- **Diseases:** Neurodegeneration with (MESH:D019636), inflammatory (MESH:D007249), Parkinson's (MESH:D010300), mitochondrial dysfunction (MESH:D028361), CSF abnormalities (MESH:D002559), vascular abnormalities (MESH:D014652), neoplastic (MESH:D009369), Alzheimer's disease (MESH:D000544), neurotoxic effects (MESH:D020258), atrophy (MESH:D001284), intracranial diseases (MESH:D020765), idiopathic epilepsy (MESH:C562694), CF (MESH:D003550), bleeding (MESH:D006470), seizure (MESH:D012640), Iron Accumulation (MESH:D000090463), idiopathic facial nerve paralysis (MESH:D020330), cerebrovascular amyloid angiopathy (MESH:C538248), otitis media (MESH:D010033), blindness (MESH:D001766), epileptic seizures (MESH:D004827), brain disorders (MESH:D001927), NBIA (MESH:D006211), developmental impairments (MESH:D007805), vestibular syndrome (MESH:D020338), age-related decline (MESH:D010024), toxicity (MESH:D064420), neuronal injury (MESH:D009410), Dementia (MESH:D003704), aggression (MESH:D010554), Cognitive Dysfunction (MESH:D003072), facial nerve paralysis (MESH:D005158)
- **Chemicals:** oxygen (MESH:D010100), zinc (MESH:D015032), Prussian blue (MESH:C000170), Omniscan (MESH:C064925), isoflurane (MESH:D007530), Iron (MESH:D007501), copper (MESH:D003300), HCl (MESH:D006851), hydroxyl radical (MESH:D017665), K4[Fe(CN)6] (-), heme iron (MESH:D006418), carbon dioxide (MESH:D002245), gadolinium (MESH:D005682), OH (MESH:C031356), lipid (MESH:D008055), potassium ferrocyanide (MESH:C031835), ROS (MESH:D017382), calcium (MESH:D002118), formalin (MESH:D005557), manganese (MESH:D008345)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Haliaeetus leucocephalus (bald eagle, species) [taxon 52644], Rattus norvegicus (brown rat, species) [taxon 10116], Felis catus (cat, species) [taxon 9685], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933945/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933945/full.md

## References

90 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933945/full.md

---
Source: https://tomesphere.com/paper/PMC12933945